Atomo Diagnostics Limited announced that on 19 December 2023, Dr. Curt LaBelle has notified the Board of his resignation as a director of the Company with immediate effect. Dr. LaBelle was appointed to the Board as a Non-Executive Director on 21 October 2016.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.031 AUD | +3.33% | +3.33% | +40.91% |
Apr. 30 | Transcript : Atomo Diagnostics Limited, Q3 2024 Earnings Call, Apr 30, 2024 | |
Apr. 15 | Atomo Diagnostics Wins AU$570,000 HIV Self-Tests Order | MT |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+40.91% | 12.54M | |
+8.38% | 218B | |
+7.43% | 183B | |
+13.29% | 134B | |
+26.08% | 106B | |
-1.33% | 61.12B | |
+4.81% | 50.89B | |
+0.51% | 40.3B | |
+2.92% | 35.53B | |
+26.60% | 32.05B |
- Stock Market
- Equities
- AT1 Stock
- News Atomo Diagnostics Limited
- Atomo Diagnostics Limited Announces the Resignation of Curt LaBelle as Non-Executive Director